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conclude that the preclinical animal models used are impressive in
their prediction of human MTD (maximum tolerated dose) and
DLT (dose limiting toxicities).
This detailed preclinical data can then be used to optimize the
design of the clinical trials. This account explains in some detail
how a clear understanding of a drugs pharmacology can lead to
improved clinical use. A greater understanding of these pharma-
cokinetic-pharmacodynamic relationships has led to optimization
of the administration and delivery of new agents in Phase I
trials.
A major new development in clinical trial design is the ability to
measure the distribution and, to a certain extent, the pharmacody-
namic effect of these new agents in a non-invasive manner. PET
(positron emission tomography) has a whole chapter dedicated
to the technique and it is clear the power of the technique will
inﬂuence the design of future clinical trials. PET can now be used
for pharmacokinetic analysis with examples, for 5-FU and temozo-
lomide given. It can be used for pharmacodynamic studies, for
example drug receptor interactions and cellular proliferation, even
detecting apoptotic cells in situ.
The concluding chapter discusses trials of the newly emerging
mechanistic drugs. It describes trial design for the compounds such
as copolymers, intended to take advantage of the leaky vasculature
of tumours, and signal transduction inhibitors where it is now
necessary to build in pharmacodynamic endpoints, showing target
inhibition/activation, into clinical trials alongside the currently
established pharmacokinetic monitoring.
In summary, this is a really extensive and comprehensive book
on the drug development process. It has detailed chapters on
potential targets, the drug design process, the drug screening
process and the design of future clinical trials to cope with these
new mechanistic based drugs. There is very little overlap between
chapters and all are written by experts in the ﬁeld. Hundreds of
useful references are included for those wanting to go further.
My one and only problem was ﬁnding the colour prints tucked
away at the back. Maybe they were too expensive to include in
the text, but I found them eventually. Congratulations to the
editors as this must have been quite a task. Very good value for
$100 and essential reading for both the scientist and Ph.D. student.
Deﬁnitely one for the library to stock.
Paul Loadman
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